Breast cancer immunotherapy may be resistant.
Immunotherapy for oncological diseases mainly targets the body’s immune system, which is activated by the use of agents that in turn kill cancer cells. However, it should be noted that if the drug is used for a long period of time, it may make the cancer foci resistant to the drug. Secondly, if one’s own immunity is poor, or the microenvironment of cancer cells is immunosuppressed, it is also easy to develop drug resistance.
For this situation, it is recommended that in the process of breast cancer treatment, one should follow the doctor’s instructions and carry out combined treatment, which can improve the immunotherapy effect of the tumor. Common methods include surgical treatment, radiotherapy, chemotherapy and targeted therapy.
The prognostic effect of breast cancer is directly related to the degree of progression of the disease, so after the occurrence of uncomfortable symptoms, one should seek medical checkup as early as possible and be treated under the guidance of doctors, and do not use medication on one’s own.